BetulA.HatipogluMD
Endocrinology • Cleveland, OHDiabetes, Lipid Metabolism, Thyroid
Professor of Medicine CWRU/University Hospitals
Dr. Hatipoglu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-3142Fax+1 216-844-3120
Summary
- Dr. Betul Hatipoglu is the Director for diabetes and obesity center and an endocrinologist in Cleveland, OH and is affiliated with University Hospitals. She received her medical degree from Istanbul University Faculty of Medicine and has been in practice 27 years. She specializes in diabetes, lipid metabolism, and thyroid and is experienced in prolactinoma, islet cell transplant surgery, and type 1 diabetes mellitus.
Education & Training
University of Illinois College of Medicine at ChicagoFellowship, Endocrinology, Diabetes, and Metabolism, 1997 - 1999
Istanbul University FomClass of 1992, MD
Michael Reese Hospital and Medical CenterResidency, Internal Medicine
Certifications & Licensure
OH State Medical License 2008 - 2026
IL State Medical License 1993 - 2011- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- The Impact of Combined Mindfulness-Based Interventions and Nutritional Counseling on Physician Burnout Start of enrollment: 2019 Dec 20
Publications & Presentations
PubMed
- 11 citationsLong-term efficacy and safety of osilodrostat in Cushing's disease: final results from a Phase II study with an optional extension phase (LINC 2).Maria Fleseriu, Beverly M K Biller, Jérôme Bertherat, Jacques Young, Betul Hatipoglu
Pituitary. 2022-12-01 - 22 citationsSerum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone.Sreevidya Subbarayan, Maria Fleseriu, Murray B. Gordon, Jessica Brzana, Laurence Kennedy
Endocrine Practice. 2012-11-01 - 26 citationsPITUITARY MRI FINDINGS IN PATIENTS WITH PITUITARY AND ECTOPIC ACTH-DEPENDENT CUSHING SYNDROME: DOES A 6-MM PITUITARY TUMOR SIZE CUT-OFF VALUE EXCLUDE ECTOPIC ACTH SYND...Divya Yogi-Morren, Mouhammed Amir Habra, Charles Faiman, James Bena, Betul Hatipoglu
Endocrine Practice. 2015-06-29
Press Mentions
Senseonics Announces a Collaboration with the University Hospitals Accountable Care Organization (UHACO) in Cleveland, OhioSeptember 13th, 2021
Health Watch: Living with Type 1 DiabetesJanuary 10th, 2020
FDA Green-Lights Marketing of New Hybrid Closed-Loop System for Type 1 DiabetesDecember 21st, 2019- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
